Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | INMT | O95050 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10129310 | 0.71 | INMT (0.36) | INMT | |
| SCHEMBL13684184 | 0.71 | INMT (0.52) | INMT | |
| SCHEMBL21324893 | 0.66 | — | — | |
| SCHEMBL21627160 | 0.60 | KDM4E (0.31) | KMT2AALDH1A1 | |
| SCHEMBL21325293 | 0.59 | — | — | |
| SCHEMBL21584067 | 0.59 | INMT (0.39) | ALDH1A1CYP1A2CYP2C19INMT | |
| SCHEMBL24952528 | 0.59 | — | — | |
| SCHEMBL21324894 | 0.57 | — | — | |
| SCHEMBL23583314 | 0.56 | — | — | |
| SCHEMBL12132129 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | UNIVERSITY OF MASSACHUSETTS (US) | 2023-06-13 | — | — | US | disclosed |
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | UNIVERSITY OF MASSACHUSETTS (US) | 2023-06-13 | — | — | US | disclosed |
| US-20200282066-A1 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | UNIV MASSACHUSETTS (US) | 2020-09-10 | — | — | US | disclosed |
| EP-0017039-B1 | PROCESS FOR THE PREPARATION OF THIAZOLIDINE-2-THIONES | BAYER AG (DE) | 1983-01-12 | — | — | EP | disclosed |
| EP-0016420-B1 | PROCESS FOR THE PREPARATION OF THIAZOLIDINE-2-THIONES | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| US-4287350-A | Process for the preparation of thiazolidine-2-thiones | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-01 | — | — | US | disclosed |
| EP-0017039-A1 | Process for the preparation of thiazolidine-2-thiones | BAYER AG (DE) | 1980-10-15 | — | — | EP | disclosed |
| EP-0016420-A1 | Process for the preparation of thiazolidine-2-thiones | BAYER AG (DE) | 1980-10-01 | — | — | EP | disclosed |
| US-4148800-A | FROM AMINOETHANOLS AND THIONYL CHLORIDE AND CARBON DISULFIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | CCL2, ACTB, TIA1 | MAPT 71/4885KMT2A 3666/4885ALDH1A1 4268/4885 |
| US-20200282066-A1 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | CCL2, ACTB, TIA1 | MAPT 71/4885KMT2A 3666/4885ALDH1A1 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.